Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PROCEPT BioRobotics (PRCT) Shares Outstanding (Diluted Average) (2020 - 2025)

Historic Shares Outstanding (Diluted Average) for PROCEPT BioRobotics (PRCT) over the last 6 years, with Q3 2025 value amounting to $55.7 million.

  • PROCEPT BioRobotics' Shares Outstanding (Diluted Average) rose 714.46% to $55.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $55.7 million, marking a year-over-year increase of 714.46%. This contributed to the annual value of $52.1 million for FY2024, which is 1030.58% up from last year.
  • PROCEPT BioRobotics' Shares Outstanding (Diluted Average) amounted to $55.7 million in Q3 2025, which was up 714.46% from $55.4 million recorded in Q2 2025.
  • In the past 5 years, PROCEPT BioRobotics' Shares Outstanding (Diluted Average) registered a high of $55.7 million during Q3 2025, and its lowest value of $4.8 million during Q1 2021.
  • In the last 5 years, PROCEPT BioRobotics' Shares Outstanding (Diluted Average) had a median value of $45.2 million in 2023 and averaged $40.8 million.
  • As far as peak fluctuations go, PROCEPT BioRobotics' Shares Outstanding (Diluted Average) skyrocketed by 80797.1% in 2022, and later soared by 188.61% in 2023.
  • Over the past 5 years, PROCEPT BioRobotics' Shares Outstanding (Diluted Average) (Quarter) stood at $16.5 million in 2021, then soared by 169.42% to $44.4 million in 2022, then increased by 6.43% to $47.3 million in 2023, then grew by 10.31% to $52.1 million in 2024, then grew by 6.91% to $55.7 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $55.7 million in Q3 2025, compared to $55.4 million in Q2 2025 and $54.9 million in Q1 2025.